CRISPR
CRISPR/Cas9 Genome Editing
In-vitro Mutagenesis
CRISPR and crRNAs
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jul 18, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
Allison Cushman-Vokoun1, Ryan J Schmidt2,3, Matthew Charles Hiemenz4
1From the Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha (Cushman-Vokoun).
基因编辑疗法在医学中提供了变革性的潜力,但需要病理学家的参与. 这篇教育论文旨在为病理学家提供有关基因编辑技术,风险及其在诊断和治疗监测中的作用的知识.
07:46CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
11:31Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells
Published on: April 2, 2016
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: